Results 101 to 110 of about 14,799,349 (142)

Flavonoid Metabolism in Tetrastigma hemsleyanum Diels et Gilg Based on Metabolome Analysis and Transcriptome Sequencing

open access: yesMolecules, 2023
Tetrastigma hemsleyanum Diels et Gilg, which is called “plant antibiotic”, possesses attractive effects including anti-inflammatory, anti-tumor, and antioxidant, and its efficacy is attributed mainly from flavonoids. However, the flavonoid composition and the expression of flavonoid-related genes are rarely studied in T. hemsleyanum.
Xiaotian Hu, Lingtai Jiang
exaly   +4 more sources

Total Flavonoids From the Dried Root of Tetrastigma hemsleyanum Diels et Gilg Inhibit Colorectal Cancer Growth Through PI3K/AKT/mTOR Signaling Pathway

open access: yesPhytotherapy Research, 2022
The dried root of Tetrastigma hemsleyanum Diels et Gilg is used as a traditional Chinese medicine in southern China, as a folk remedy for carcinomas and gastrointestinal diseases. The total flavonoids of T.
Guoyin Kai, Chengtao Sun
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Physicochemical characterizations of starches isolated from Tetrastigma hemsleyanum Diels et Gilg

International Journal of Biological Macromolecules, 2021
Physicochemical characteristics of starch isolated from Tetrastigma hemsleyanum Diels et Gilg (T. hemsleyanum) tuber root of 4 different origins were firstly analyzed in this study. The starch granules of T. hemsleyanum tuber root were oval or globular, showed unimodal distribution with average size of 21.66-28.79 μm. T.
Wanxin, Gong   +5 more
openaire   +2 more sources

Antibacterial Mechanism of Tetrastigma hemsleyanum Diels et Gilg's Polysaccharides by Metabolomics Based on HPLC/MS

International Journal of Biological Macromolecules, 2019
Tetrastigma hemsleyanum Diels et Gilg (THDG) is used as a Chinese traditional anti-inflammatory medicine for about thousands of years. In this work, Tetrastigma hemsleyanum Diels et Gilg's polysaccharide (TP) can inhibit E. coli's growth in initial dosing period.
Zhenyu Lin, Shaohuang Weng, Zhou Chen
exaly   +3 more sources

Home - About - Disclaimer - Privacy